Litcius/Paper detail

Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials

Zeinab Davoodi‐Moghaddam, Farideh Jafari‐Raddani, Mahda Delshad, Atieh Pourbagheri‐Sigaroodi, Davood Bashash

2023Journal of Cancer Research and Clinical Oncology24 citationsDOIOpen Access PDF

Topics & Concepts

PI3K/AKT/mTOR pathwayClinical trialProtein kinase BMedicineCancerPharmacologyOncologyCancer researchInternal medicineSignal transductionBiologyBiochemistryPI3K/AKT/mTOR signaling in cancerCancer Mechanisms and TherapyAdvanced Breast Cancer Therapies
Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials | Litcius